Daxor announces the launch of a new service designed to drive faster adoption and provide greater prescriber access to Daxor’s innovative blood volume analysis technology, BVA. Daxor’s ezBVA Lab is a state-of-the-art CLIA certified facility located at Daxor’s Oak Ridge facility that provides on-demand, next day blood volume analysis results. “Daxor’s ezBVA Lab requires no capital investment from our customers while easily integrating into workflow with eligible reimbursement by both private and public insurance,” said Michael Feldschuh, CEO of Daxor Corporation. “We are excited to provide a simpler, cost-effective solution for hospitals and clinicians to adopt our technology who do not have our analyzer systems available in their lab but will instead utilize Daxor’s paid lab service, so providers can achieve optimal fluid management for their patients.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
 
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DXR:
- Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference
 - Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering
 - Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
 - Daxor Nosedives on Stock Offering
 - Daxor Corporation Announces Proposed Underwritten Public Offering
 
